Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (5): 1002-1006. doi: 10.19723/j.issn.1671-167X.2021.05.032

Previous Articles     Next Articles

Arrhythmogenic right ventricular cardiomyopathy associated with arrhythmia-induced cardiomyopathy: A case report

CHEN Shao-min,SUN Chao(),WANG Xin-yu,ZHANG Yuan,LIU Shu-wang   

  1. Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100191, China
  • Received:2019-09-22 Online:2021-10-18 Published:2021-10-11
  • Contact: Chao SUN E-mail:cshooll@hotmail.com

RICH HTML

  

Abstract:

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a kind of inherited cardio-myopathy, which is characterized by fibro-fatty replacement of right ventricular myocardium, leading to ventricular arrhythmia. However, rapid atrial arrhythmias are also common, including atrial fibrillation, atrial flutter and atrial tachycardia. Long term rapid atrial arrhythmia can lead to further deterioration of cardiac function. This case is a 51-year-old male. He was admitted to Department of Cardiology, Peking University Third Hospital with palpitation and fatigue after exercise. Electrocardiogram showed incessant atrial tachycardia. Echocardiography revealed dilation of all his four chambers, especially the right ventricle, with the left ventricular ejection fraction of 40% and the right ventricular hypokinesis. Cardiac magnetic resonance imaging found that the right ventricle was significantly enlarged, and the right ventricular aneurysm had formed; the right ventricular ejection fraction was as low as 8%, and the left ventricular ejection fraction was 35%. The patients met the diagnostic criteria of ARVC, and both left and right ventricles were involved. His physical activities were restricted, and metoprolol, digoxin, spironolactone and ramipril were given. Rivaroxaban was also given because atrial tachycardia could cause left atrial thrombosis and embolism. His atrial tachycardia converted spontaneously to normal sinus rhythm after these treatments. Since the patient had severe right ventricular dysfunction, frequent premature ventricular beats and non-sustained ventricular tachycardia on Holter monitoring, indicating a high risk of sudden death, implantable cardioverter defibrillator (ICD) was implanted. After discharge from hospital, physical activity restriction and the above medicines were continued. As rapid atrial arrhythmia could lead to inappropriate ICD shocks, amiodarone was added to prevent the recurrence of atrial tachycardia, and also control ventricular arrhythmia. After 6 months, echocardiography was repeated and showed that the left ventricle diameter was reduced significantly, and the left ventricular ejection fraction increased to 60%, while the size of right ventricle and right atrium decreased slightly. According to the clinical manifestations and outcomes, he was diagnosed with ARVC associated with arrhythmia induced cardiomyopathy. According to the results of his cardiac magnetic resonance imaging, the patient had left ventricular involvement caused by ARVC, and the persistent atrial tachycardia led to left ventricular systolic dysfunction.

Key words: Arrhythmogenic right ventricular cardiomyopathy, Atrial arrhythmias, Arrhythmia-induced cardiomyopathy

CLC Number: 

  • R541

Figure 1

Electrocardiogram: Atrial tachycardia with 2 ∶1 conduction"

Figure 2

Holter: Atrial tachycardia with 2 ∶1 conduction, non sustained ventricular tachycardia with a left bundle branch block morphology and superior axis (negative QRS complex in leads Ⅱ, Ⅲ and aVF, and positive QRS complex in lead aVL)"

Figure 3

Cardiac magnetic resonance imaging: Enlarged right ventricle and subepicardial delayed gadolinium enhancement in the free wall of right ventricle, the anterior wall, lateral wall and inferior wall in left ventricle"

Figure 4

ECG in sinus rhythm: Epsilon wave in leads V1 to V6, and inverted T wave in leads V1 to V4"

Table 1

Changes in echocardiographic parameters"

Items During hospitalization Six month after discharge
Left ventricular end-diastolic diameter/mm 56.5 52.0
Left atrial area/cm2 23 23
Right ventricular outflow tract diameter/mm 45 43
Right atrial area/cm2 21 18
Left ventricular ejection fraction/% 40 60
[1] Gandjbakhch E, Redheuil A, Pousset F, et al. Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy/dysplasia: JACC state-of-the-art review [J]. J Am Coll Cardiol, 2018, 72(7):784-804.
doi: S0735-1097(18)35284-7 pmid: 30092956
[2] 中华医学会心血管病学分会精准心血管病学学组, 中国医疗保健国际交流促进会, 精准心血管病分会, 等. 单基因遗传性心血管疾病基因诊断指南 [J]. 中华心血管病杂志, 2019, 47(3):175-196.
[3] Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria [J]. Circulation, 2010, 121(13):1533-1541.
doi: 10.1161/CIRCULATIONAHA.108.840827
[4] Morimoto S, Sekiguchi M, Okada R, et al. Two autopsied cases of arrhythmogenic right ventricular dysplasia [J]. J Cardiol, 1990, 20(4):1025-1036.
pmid: 2133713
[5] Vila J, Pariaut R, Moise NS, et al. Structural and molecular pathology of the atrium in boxer arrhythmogenic right ventricular cardiomyopathy [J]. J Vet Cardiol, 2017, 19(1):57-67.
doi: S1760-2734(16)30073-X pmid: 27769725
[6] Wu L, Bao J, Liang E, et al. Atrial involvement in arrhythmo-genic right ventricular cardiomyopathy patients referred for ventri-cular arrhythmias ablation [J]. J Cardiovasc Electrophysiol, 2018, 29(10):1388-1395.
doi: 10.1111/jce.2018.29.issue-10
[7] Cardona-Guarache R, Åström-Aneq M, Oesterle A, et al. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment [J]. J Cardiovasc Electrophysiol, 2019, 30(10):1801-1810.
doi: 10.1111/jce.v30.10
[8] Saguner AM, Ganahl S, Kraus A, et al. Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia [J]. Circ J, 2014, 78(12):2854-2861.
pmid: 25327952
[9] Camm CF, James CA, Tichnell C, et al. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardio-myopathy [J]. Heart Rhythm, 2013, 10(11):1661-1668.
doi: 10.1016/j.hrthm.2013.08.032
[10] Sugumar H, Prabhu S, Voskoboinik A, et al. Arrhythmia induced cardiomyopathy [J]. J Arrhythm, 2018, 34(4):376-383.
doi: 10.1002/joa3.2018.34.issue-4
[11] Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement [J]. Eur Heart J, 2015, 36(46):3227-3237.
[12] Haugaa KH, Haland TF, Leren IS, et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis [J]. Europace, 2016, 18(7):965-972.
doi: 10.1093/europace/euv340
[1] Yuanmei LIU, Yicheng FU, Jingxin HAO, Fuchun ZHANG, Huilin LIU. Construction and validation of a nomogram for predicting in-hospital postoperative heart failure in elderly patients with hip fracture [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 874-883.
[2] Ying WEI,Ming CUI,Shuwang LIU,Haiyi YU,Wei GAO,Lei LI. Different levels and clinical significance of growth differentiation factor-15 in patients with atrial fibrillation [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 715-721.
[3] Shengjia PENG,Yu QI,Lijie SUN,Dan LI,Xinyu WANG,Jiangli HAN,Baoxia CHEN,Yuan ZHANG. Afferent baroreflex failure with hyponatremia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 357-361.
[4] XU Hao,ZHANG Guo-dong,FAN Guang-pu,CHEN Yu. Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1139-1143.
[5] Huan LIU,Ying-dong HE,Jin-bo LIU,Wei HUANG,Na ZHAO,Hong-wei ZHAO,Xiao-hua ZHOU,Hong-yu WANG. Predictive value of vascular health indicators on newly cardiovascular events: Preliminary validation of Beijing vascular health stratification system [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 514-520.
[6] Chuan REN,Xiao-yue WU,Wei ZHAO,Li-yuan TAO,Ping LIU,Wei GAO. Protective effect of cardiopulmonary fitness on patients with high risk of atherosclerotic cardiovascular disease [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 152-157.
[7] Wen-qiang SUN,Zhou ZHAO,Qing GAO,Zeng-qiang HAN,Wei YANG,Bo LIAN,Gang LIU,Sheng-long CHEN,Yu CHEN. Effects of intraoperative graft flow measurements on the early mid-term outcomes after off-pump coronary artery bypass grafting [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 851-855.
[8] Jing ZHANG,Su-fang LI,Hong CHEN,Jun-xian SONG. Role of miR-106b-5p in the regulation of gene profiles in endothelial cells [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 221-227.
[9] ZHAO Can, HU Jing-Min, GUO Dan-Jie. Diagnostic value of D-dimer combined with Wells score for suspected pulmonary embolism [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 828-832.
[10] REN Shu-tang, WANG Yong, ZHOU Jian-hua, LONG Jin, WANG Cui-hua, LI Dong-bei, HUANG Yun-zhou. Echocardiographic diagnosis of infracardiac total anomalous pulmonary venous connection [J]. Journal of Peking University(Health Sciences), 0, (): 883-888.
[11] REN Shu-tang, WANG Yong, ZHOU Jian-hua, LONG Jin, WANG Cui-hua, LI Dong-bei, HUANG Yun-zhou. Echocardiographic diagnosis of infracardiac total anomalous pulmonary venous connection [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 883-888.
[12] FENG Qi-chen, LI Xuan, LUAN Jing-yuan, WANG Chang-ming, LI Tian-run. Significance of renal filtration fraction evaluation of renal artery stenting for atherosclerotic renal artery stenosis treatment [J]. Journal of Peking University(Health Sciences), 2017, 49(1): 158-163.
[13] LIU Teng-fei, ZHANG Jing-wei, CHEN Xia-huan, FENG Xue-ru, BAI Zhong-sheng, LIU Mei-lin. Association between CMTM5 gene rs723840 single nucleotide polymorphism and high on asprin platelet reactivity [J]. Journal of Peking University(Health Sciences), 2015, 47(6): 905-909.
[14] LIU Teng-fei, ZHANG Jing-wei, CHEN Xia-huan, FENG Xue-ru, BAI Zhong-sheng, LIU Mei-lin. Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabete and coronary artery disease [J]. Journal of Peking University(Health Sciences), 2015, 47(6): 920-924.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!